N-(3-Bromo-4-(trifluoromethoxy)phenyl)acetamide

Catalog No. :
ACPENS075
CAS No. :
755030-17-2
Molecular Formula :
C9H7BrF3NO2
Molecular Weight :
298.06

IUPAC Name:N-(3-bromo-4-(trifluoromethoxy)phenyl)acetamide

N-(3-Bromo-4-(trifluoromethoxy)phenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$136.00Login to see priceInquiryInquiry
1g95%$308.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3-Bromo-4-(trifluoromethoxy)phenyl)acetamide
IUPAC NameN-(3-bromo-4-(trifluoromethoxy)phenyl)acetamide
MDL No.MFCD13176598
Molecular FormulaC9H7BrF3NO2
Molecular Weight298.06
SMILESCC(NC1=CC=C(OC(F)(F)F)C(Br)=C1)=O
InChI KeyRHHGKDDKXSSPOF-UHFFFAOYSA-N
Synonym3'-Bromo-4'-(trifluoromethoxy)acetanilide 99%;4-Acetamido-2-bromo-alpha,alpha,alpha-trifluoroanisole, N-[3-Bromo-4-(trifluoromethoxy)phenyl]acetamide;3'-Bromo-4'-(trifluoromethoxy)acetanilide99%;RHHGKDDKXSSPOF-UHFFFAOYSA-N;3'-Bromo-4'-(trifluoromethoxy)acetanilide;Acetamide, N-[3-bromo-4-(trifluoromethoxy)phenyl]-;4-Acetamido-2-bromo-α,α,α-trifluoroanisole N-[3-Bromo-4-(trifluoromethoxy)phenyl]acetamide;N-[3-bromo-4-(trifluoromethoxy)phenyl]acetamide
CAS No.755030-17-2

Synthetic Route by SureRoute

1. ACPENS075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSGQL259 route compound structure diagram
    ACSGQL259191602-54-7 In Stock
  4. Then
  5. ACPENS075 route product structure diagram
    ACPENS075755030-17-2
Inquiry

2. ACPENS075 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACSGQL259 route compound structure diagram
    ACSGQL259191602-54-7 In Stock
  4. Then
  5. ACPENS075 route product structure diagram
    ACPENS075755030-17-2
Inquiry

Comments (0)